3.0450
+0.0150
+(0.50%)
At close: January 31 at 8:06:30 AM GMT+1
Research analysis
Earnings estimate
| Currency in USD | Current qtr. (Dec 2024) | Next qtr. (Mar 2025) | Current year (2024) | Next year (2025) |
|---|---|---|---|---|
| No. of analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low estimate | 0 | 0 | 0 | 0 |
| High estimate | 0 | 0 | 0 | 0 |
| Year ago EPS | -- | -- | -- | -- |
Revenue estimate
| Currency in USD | Current qtr. (Dec 2024) | Next qtr. (Mar 2025) | Current year (2024) | Next year (2025) |
|---|---|---|---|---|
| No. of analysts | 8 | 4 | 8 | 8 |
| Avg. Estimate | -- | -- | -- | -- |
| Low estimate | -- | -- | -- | -- |
| High estimate | -- | -- | -- | -- |
| Year ago sales | -- | -- | -- | -- |
| Sales growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS trend
| Currency in USD | Current qtr. (Dec 2024) | Next qtr. (Mar 2025) | Current year (2024) | Next year (2025) |
|---|---|---|---|---|
| Current estimate | 0 | 0 | 0 | 0 |
| 7 days ago | 0 | 0 | 0 | 0 |
| 30 days ago | 0 | 0 | 0 | 0 |
| 60 days ago | 0 | 0 | 0 | 0 |
| 90 days ago | 0 | 0 | 0 | 0 |
EPS revisions
| Currency in USD | Current qtr. (Dec 2024) | Next qtr. (Mar 2025) | Current year (2024) | Next year (2025) |
|---|---|---|---|---|
| Up last 7 days | -- | -- | -- | -- |
| Up last 30 days | -- | -- | -- | -- |
| Down last 7 days | -- | -- | -- | -- |
| Down last 30 days | -- | -- | -- | -- |
Growth estimates
| Current qtr. | Next qtr. | Current year | Next year | |
|---|---|---|---|---|
| SP4P.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & downgrades
| Initiated | Rodman & Renshaw: Buy | 11/14/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 8/15/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/13/2024 |
| Initiated | JonesTrading: Buy | 4/17/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 4/1/2024 |
| Maintains | Lake Street: Buy to Buy | 3/5/2024 |